Inventor · disambiguated record
Songqing Na
Also filed as: NA SONGQING
3 granted patents·11 pending applications·7 citations·filing 2001–2024
58Inventor score
Top patents by PatentIndex Score
14 records- 0181US11623956B2Anti-human CD19 antibodiesLILLY CO ELI·Filed 2021·Granted Apr 11, 2023·2 cites·51 claims
- 0280US9718884B2Anti-TNF-/anti-IL-23 bispecific antibodiesLILLY CO ELI·Filed 2015·Granted Aug 1, 2017·5 cites·9 claims
- 0362US2025197493A1Lag-3 agonist antibodiesLILLY CO ELI·Filed 2024·Application pending·0 cites
- 0458US2023192837A1Human tumor necrosis factor alpha antibodiesLILLY CO ELI·Filed 2022·Application pending·0 cites
- 0557US2024082414A1Human tumor necrosis factor alpha antibody glucocorticoid conjugatesLILLY CO ELI·Filed 2023·Application pending·0 cites
- 0656US2024100176A1Human interleukin-4 receptor alpha antibody glucocorticoid conjugatesLILLY CO ELI·Filed 2023·Application pending·0 cites
- 0754US11891441B2Human interleukin-4 receptor alpha antibodiesLILLY CO ELI·Filed 2022·Granted Feb 6, 2024·0 cites·69 claims
- 0841US2019040156A1ANTI-TNF- / ANTI-IL-23 IgG BISPECIFIC ANTIBODIESLILLY CO ELI·Filed 2018·Application pending·0 cites
- 0941US2004167074A1Therapeutic applications of mFLINT polypeptidesFiled 2004·Application pending·0 cites
- 1039US2004236088A1Novel polypeptide analogs and fusions and their methods of useFiled 2002·Application pending·0 cites
- 1138US2003100502A1Treating musculoskeletal disorders using lp85 and analogs thereofFiled 2001·Application pending·0 cites
- 1234US2005069540A1Treating b-cell mediated diseases by modulating dr6 activityFiled 2002·Application pending·0 cites
- 1334US2006142558A1Novel proteins and their usesNA SONGQING·Filed 2003·Application pending·0 cites
- 1430US2004043022A1Treating t-cell mediated diseases by modulating dr6 activityFiled 2001·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Songqing Na files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →